Clinical Trial

International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 21, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Pleuropulmonary Blastoma (PPB) is very rare and there is no established "standard" or "best" therapy. For many years, children with PPB around the world have been treated according to decisions made case-by-case in many different hospitals by many different physicians. No treatment has been tested in a large group of PPB patients. The goal is to treat many children with one treatment program and to learn the results of the treatment.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2011-11-01; most recent amendment 2024-08-20.
Status change: Recruiting → Active, Not Recruiting 2019-05-16
Trial Details
NCT Number NCT01464606
Lead Sponsor Children's Hospitals and Clinics of Minnesota
Conditions Pleuropulmonary Blastoma
Enrollment 156 participants
Start Date 2009-12-22
Primary Completion 2025-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2024-08-21